Overview Fundamentals API Earnings EOD API Sample Code Pricing

Janux Therapeutics Inc (JANX NASDAQ) stock market data APIs

$47.25 1.83(4%) as of July 23, 2024
Price chart is built with Anychart

Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr) platforms technology to treat patients suffering from cancer. The company's clinical candidates comprise JANX007, a prostate-specific membrane antigen or PSMA-TRACTr, which is in Phase 1 clinical trial in adults for the treatment of metastatic castration-resistant prostate cancer (mCRPC) and the vasculature of other tumors; and JANX008, an epidermal growth factor receptor or EGFR-TRACTr that is in Phase 1 clinical trial for the treatment of multiple solid cancers, including colorectal cancer, squamous cell carcinoma of the head and neck, non-small cell lung cancer, and renal cell carcinoma. Its development pipeline also consists of discovery stage products. The company has strategic research collaboration agreement with Merck Sharp & Dohme Corp. to develop TRACTr product candidates. Janux Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.

Janux Therapeutics Inc Financial Data Overview

45.42
47.25
-
47.65
45.09
5.65-65.6
2 474 M
51 851 K
7 287 K
-0.3
3.576
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'JANX',
Type: 'Common Stock',
Name: 'Janux Therapeutics Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00ZHSKH11',
ISIN: NULL,
CUSIP: NULL,
CIK: '1817713',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2021-06-11',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Janux Therapeutics Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 7 287 K
  • EBITDA -70 825 000
  • Earnings Per Share -1.2
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Janux Therapeutics Inc Earnings via APIs

  • Latest Release 2024-05-07
  • EPS/Forecast -0.33

Get Janux Therapeutics Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com